Our genetic tests are done by a simple, painless mouth swab and carried out once in a lifetime.
The genetic profile that everybody should have
Cypass® is an innovative genetic test that evaluates overall risk of adverse drug events. It integrates patient’s abilities to activate and eliminate drugs with drug-drug interactions simultaneously, thus allowing selecting for safer and more effective drug regimens that can improve drug treatment outcomes and reduce or avoid adverse drug reactions. More information
Evaluates risks of thrombosis under contraceptive pills
Pill Protect® is an ingenious CE-IVD marked medical test that uses genetic and clinical data to identify women at risk of developing blood clots (thrombosis) when using contraceptive pills. It is the first clinically validated test and the best performing tool to identify women at risk of developing thrombosis under contraceptive pills. More information
The test that allows matching nutrition to genes
Nutripass® is an exhaustive genetic and nutritional analysis that allows to tailor dietary habits and helps to optimize and improve health.
The most comprehensive genetic profile providing an overall view of inherited risk factors
Exclusive offers the most comprehensive overview of inherited risk factors. It is an open door into the personalized medicine of the 21st century, providing a unique opportunity to tailor therapeutic options, nutrition and lifestyle to allow personalized medical treatments and enable prevention of the diseases for which we are genetically predisposed.
Predicts toxicity and treatment efficacy in patients treated with Irinotecan
Genetic analysis of UGT1A1 gene variants that predicts toxicity and treatment efficacy of Irinotecan treatment for metastatic colorectal cancer patients .
The most comprehensive genetic test to evaluate risk of adverse drug effects
Analysis of over 120 genetic variants in genes encoding principal drug metabolizing pathways; in depth analysis that evaluates overall risk of adverse drug effects, including anti-cancer drugs.
Allows to assess sensibility to Carbamazepine
Analyses of genetic variants associated with safety of Carbamazepine drug treatment.
The test that allows tailoring prescription of Clopidogrel blood thinners
Analyses of the genetic variants associated with efficacy and safety of Clopidogrel.
A cardinal issue in case of prescription of coumarins
Analysis of genetic variants associated with efficacy and safety of coumarins.
The test that allows to assess hypersensitivity to Abacavir and Flucloxacillin drugs
Analysis of genetic variants associated with hypersensitivity to Abacavir treatment and Flucloxacillin-induced liver injury.
The test that helps predict efficacy of antiviral treatment against Hepatitis-C virus, as well as the spontaneous clearance of the virus
Analysis of gene variants that help predicting efficacy of combination antiviral therapy PEG-IFN alpha/RBV.
The tests that helps predicting efficacy and safety of diverse statin drugs
Analysis of genetic variants related to metabolism and toxicity of statin drugs.
Essential when quitting smoking
Genetic test that predicts the medication that will have the highest impact on success of quitting cigarettes smoking.
Assesses patient’s ability to respond to Tamoxifen treatment
Analysis of genetic variants predicting efficiency of Tamoxifen treatment.
The gene associated with toxicity of 5-fluorouracil (5-FU) and fluoropyrimidine capecitabine treatments
Analysis of DPYD gene mutations associated with severe or lethal toxicity upon treatment with 5-fluorouracil (5-FU) or a widely prescribed oral fluoropyrimidine capecitabine (Xeloda).
Assesses chemotherapy response and adverse effects of cyclophosphamide, epirubicin, and oxaliplatine
Analysis of the relevant genetic variants in the GSTP1 gene, associated with chemotherapy response and adverse effects of cyclophosphamide, epirubicin, and oxaliplatine.
Assesses efficacy of Thiopurine treatments
Analysis of genetic variants associated with efficacy of Thiopurine treatment in autoimmune diseases or leukaemia.
The genetic profile that protects heart
Genetic test that allows to estimate risk of developping coagulation conditions, hypercholesterolemia, hypertension and cardiovascular diseases.
Measures risk of developing thromboembolism related to a hormone replacement therapy for menopause
Analysis of genetic variants related to the risk of thrombosis under hormone replacement therapy. Using the proprietary algorithm, genetic and clinical risk factors are taken into account to quantify the risk.
Identifies Factor V-Leiden genetic variant
Analysis searching for the presence of absence of Factor V-Leiden genetic variant, associated with increased risk of developing deep-vein thrombosis and pulmonary embolism.
Identifies Factor II-G20210A genetic variant
Analysis looking for presence of absence of Factor II-G20210A genetic variant, associated with increased risk of developing deep-vein thrombosis and pulmonary embolism.
Infoms about osteoporosis risks
Analysis of genetic variants in a number of genes associated to hormone receptors and skeletal proteins. A smart approach to fight one amongst the most prevalent “silent diseases” of the 21st century.
Patient’s eyesight is of great concern
Analysis of genetic variants associated with glaucoma and age-related macular degeneration (AMD). These diseases may ineluctably hamper eyesight performances before diagnosis is made.
Assesses genetic risk to develop Age-Related Macular Degeneration
Analyses of genetic variants associated with age-related macular degeneration.
Assesses genetic risk to develop Exfoliation Glaucoma
Analyses of mutations associated with exfoliation glaucoma.
Informs about hemochromatosis risk
Analysis of the genetic variants responsible for familial hemochromatosis, severe metabolic disease, that is often overlooked.
Homocysteine risk is under scrutiny
Analysis of genetic variants in MTHFR gene associated with high homocysteine levels.
A look inside the digestive system
Investigation of genetic variants involved in gluten and lactose intolerance, together with parameters of increased risks for immune and inflammatory types of gastrointestinal disorders.
Do you suffer from bloating and repetitive abdominal pain?
A classical undiagnosed problem. Look for genetic variants linked to gluten impaired metabolisation.
Problems with dairy products?
Analysis of the genetic variant leading to lactose intolerance.
The allele strongly associated with autoimmune disorders
Genetic test assessing the risk of developing certain autoimmune disorders such as ankylosing spondylitis, reactive arthritis (Reiter’s Syndrome), psoriatic arthritis, ulcerative colitis associated spondyloarthritis, anterior uveitis and iritis.
For prevention and personalized care of periodontitis
Genetic test that assesses risk of developing periodontitis.
Favours harmonious ageing
Many age-related diseases have as origin the interaction between the content of our genes and our lifestyle. Everyone does not fight with the same weapons against osteoporosis or cardiovascular disease. The knowledge of the content of our genes allows personalized medical treatments and enables disease prevention.
Measures detoxification abilities and capacity to buffer oxydative stress
Analysis of genetic variants that impact fuction of the major detoxification pathways; informs about the ability to detoxify diverse toxic substances and buffer oxidative stress.
Improve your performances
A comprehensive genetic analysis that enables to adapt training, recovery and detoxification strategies after excercice to individual, with aim to improve sport performances.